CAS: 2295925-90-3
Ureidolacosamide ((R)-N-Benzyl-2-(3-benzylureido)-3-methoxypropanamide)
CAS:2295925-90-3
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof
Formula:
C19H23N3O3
Color and Shape:
White Solid
Molecular weight:
341.17394
Estimated delivery in United States, on Tuesday 7 Jan 2025
(R)-N-Benzyl-2-(3-benzylureido)-3-methoxypropanamide
CAS:2295925-90-3
Formula:
C19H23N3O3
Purity:
95%
Color and Shape:
Solid
Molecular weight:
341.4042
Ref: IN-DA01XB35
| 25mg | 563.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Lacosamide EP Impurity I (R-Isomer)
CAS:2295925-90-3
Formula:
C19H23N3O3
Color and Shape:
White To Off-White Solid
Molecular weight:
341.41
Ref: 4Z-L-2819
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Lacosamide impurity I: (R)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide
Controlled ProductCAS:2295925-90-3
Applications Lacosamide impurity I: (R)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide is an impurity of lacosamide (L098500), a medication used for …
Formula:
C19H23N3O3
Color and Shape:
Neat
Molecular weight:
341.4
Ref: TR-L098515
| 10mg | 264.00 € | ||
| 25mg | 511.00 € | ||
| 100mg | 1,744.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
Lacosamide impurity I: (R)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide
CAS:2295925-90-3
Please enquire for more information about Lacosamide impurity I: (R)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide including the price, delivery time …
Formula:
C19H23N3O3
Purity:
Min. 95%
Molecular weight:
341.4 g/mol
Ref: 3D-VRD92590
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
